Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, May 12, 2022
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
Patrick Trucchio Maintained (VIR) at Strong Buy with Decreased Target to $125 on, May 12th, 2022
Patrick Trucchio of HC Wainwright & Co., Maintained "Vir Biotechnology, Inc." (VIR) at Strong Buy with Decreased Target from $200 to $125 on, May 12th, 2022.
Patrick has made no other calls on VIR in the last 4 months.
There are 2 other peers that have a rating on VIR. Out of the 2 peers that are also analyzing VIR, 1 agrees with Patrick's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Joel Beatty of "Baird" Upgraded from Sell to Hold and Decreased Target to $28 on, Thursday, March 3rd, 2022
This is the rating of the analyst that currently disagrees with Patrick
- Joseph Stringer of "Needham" Maintained at Strong Buy with Decreased Target to $35 on, Friday, May 6th, 2022
